《大行報告》花旗下調小米(01810.HK)目標價至27元 評級「買入」
花旗發表報告表示,小米(01810.HK)將於今日公布2021年第四季度業績,雖然消費者需求疲軟、供應鏈受阻,但預期小米業績仍將較市場預期略好,料其去年第四季經調整盈利按年增長27%至42億元人民幣,收入則升16%至816億元人民幣。
花旗稱,小米前景仍充滿挑戰,會關注小米管理層對供需的評論,以及有關投資汽車業務的費用。該行稱,小米目前股價相當於2022年預測市盈率11倍具吸引力,重申「買入」評級。將目標價由32元調低至27元,建議有耐心的投資者增持股票,待市場恢復信心。(me/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.